Last reviewed · How we verify
acetam/ketoro tromet group
acetam/ketoro tromet group is a Fixed-dose combination analgesic/NSAID Small molecule drug developed by Universidade Estadual de Ponta Grossa. It is currently in Phase 3 development for Acute pain management (indication not fully specified in available data).
This combination drug likely combines acetaminophen's analgesic and antipyretic effects with ketoprofen's nonsteroidal anti-inflammatory properties, potentially enhanced by trometamol as a buffering agent for improved tolerability.
This combination drug likely combines acetaminophen's analgesic and antipyretic effects with ketoprofen's nonsteroidal anti-inflammatory properties, potentially enhanced by trometamol as a buffering agent for improved tolerability. Used for Acute pain management (indication not fully specified in available data).
At a glance
| Generic name | acetam/ketoro tromet group |
|---|---|
| Sponsor | Universidade Estadual de Ponta Grossa |
| Drug class | Fixed-dose combination analgesic/NSAID |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 3 |
Mechanism of action
Acetaminophen inhibits prostaglandin synthesis in the central nervous system to reduce pain and fever. Ketoprofen is an NSAID that inhibits cyclooxygenase enzymes to reduce inflammation and pain. Trometamol (tromethamine) is a buffer that may enhance absorption and reduce gastrointestinal irritation from the NSAID component.
Approved indications
- Acute pain management (indication not fully specified in available data)
Common side effects
- Gastrointestinal upset
- Dyspepsia
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- acetam/ketoro tromet group CI brief — competitive landscape report
- acetam/ketoro tromet group updates RSS · CI watch RSS
- Universidade Estadual de Ponta Grossa portfolio CI
Frequently asked questions about acetam/ketoro tromet group
What is acetam/ketoro tromet group?
How does acetam/ketoro tromet group work?
What is acetam/ketoro tromet group used for?
Who makes acetam/ketoro tromet group?
What drug class is acetam/ketoro tromet group in?
What development phase is acetam/ketoro tromet group in?
What are the side effects of acetam/ketoro tromet group?
Related
- Drug class: All Fixed-dose combination analgesic/NSAID drugs
- Manufacturer: Universidade Estadual de Ponta Grossa — full pipeline
- Therapeutic area: All drugs in Pain Management
- Indication: Drugs for Acute pain management (indication not fully specified in available data)
- Compare: acetam/ketoro tromet group vs similar drugs
- Pricing: acetam/ketoro tromet group cost, discount & access